Pyrimethamine (58-14-0)
DOI: https://doi.org/10.22427/NTP-DATA-DTXSID9021217
Study Results
Chronic Bioassay Level of Evidence
An overview of chronic evidence from Rats studies.
Rats |
View
|
View
|
An overview of chronic evidence from Mice studies.
Mice |
View
- Inadequate Study, Male, Mice
|
View
|
Genetic Toxicology
An overview of Genetic Toxicology Mammalian Cell Cytogenetics study conclusions related to Pyrimethamine (58-14-0).
Mammalian Cell Cytogenetics |
CA
|
SCE
|
|
|
An overview of Genetic Toxicology Bacterial Mutagenicity study conclusions related to Pyrimethamine (58-14-0).
Bacterial Mutagenicity |
View
|
Citation Information
NTP. Pyrimethamine (58-14-0). Chemical Effects in Biological Systems (CEBS). Research Triangle Park, NC (USA): National Toxicology Program (NTP).
Publications
TR-077
Bioassay of Pyrimethamine for Possible Carcinogenicity (CASRN 58-14-0)
Haworth, S., Lawlor, T., Mortelmans, K., Speck, W., and Zeiger, E. Salmonella mutagenicity test results for 250 chemicals Environ. Mutagen. Vol. 5 (Suppl 1) (1983) 3-142
Study Data
Toxicity and Carcinogenicity Studies
Evaluation of the Chronic Toxicity and Carcinogenicity of Pyrimethamine (58-14-0) in Male F344 Rats Exposed via Dosed Feed
Evaluation of the Chronic Toxicity and Carcinogenicity of Pyrimethamine (58-14-0) in Female F344 Rats Exposed via Dosed Feed
Evaluation of the Chronic Toxicity and Carcinogenicity of Pyrimethamine (58-14-0) in Male B6C3F1 Mice Exposed via Dosed Feed
Evaluation of the Chronic Toxicity and Carcinogenicity of Pyrimethamine (58-14-0) in Female B6C3F1 Mice Exposed via Dosed Feed
Genetic Toxicology Studies
Genetic Toxicity Evaluation of Pyrimethamine in Salmonella/E.coli Mutagenicity Test or Ames Test. Study 368591
Other NTP Studies
28-Day Immunotoxicity Evaluation (IMM96013) of AZT + Pyrimethamine Combination (Aids) (AZT/PYRIMETH) in B6C3F1 Mice via Gavage
B6CF1 Mice Individual and Summary Data